D-Wave Quantum Advances Drug Discovery with JT Partnership

D-Wave Quantum ( (QBTS) ) has issued an update.

D-Wave Quantum Inc. and Japan Tobacco Inc.’s pharmaceutical division are teaming up to revolutionize drug discovery by integrating quantum computing and AI. Their joint proof-of-concept project is designed to enhance the speed and effectiveness of AI in identifying new ‘first-in-class’ small molecule pharmaceuticals. D-Wave’s expertise in quantum computing will be leveraged to expand the capabilities of JT’s AI systems, potentially setting a new standard in the pharmaceutical industry and accelerating the development of innovative drugs.

Find detailed analytics on QBTS stock on TipRanks’ Stock Analysis page.